Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Working Capital Changes (2016 - 2025)

Apyx Medical (APYX) has disclosed Other Working Capital Changes for 15 consecutive years, with -$228000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 27.62% year-over-year to -$228000.0, compared with a TTM value of -$237000.0 through Dec 2025, up 72.35%, and an annual FY2025 reading of -$237000.0, up 72.35% over the prior year.
  • Other Working Capital Changes was -$228000.0 for Q4 2025 at Apyx Medical, down from $425000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.5 million in Q2 2021 and bottomed at -$1.4 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$86900.0, with a median of -$234500.0 recorded in 2024.
  • The sharpest move saw Other Working Capital Changes skyrocketed 5351.85% in 2021, then tumbled 25600.0% in 2023.
  • Year by year, Other Working Capital Changes stood at -$1.4 million in 2021, then soared by 100.15% to $2000.0 in 2022, then crashed by 25600.0% to -$510000.0 in 2023, then soared by 38.24% to -$315000.0 in 2024, then increased by 27.62% to -$228000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for APYX at -$228000.0 in Q4 2025, $425000.0 in Q3 2025, and -$397000.0 in Q2 2025.